Atipamezole Attenuated Telazol/Xylazine-Induced Expression of C-Fos in Rat Thalamencephal and Cerebral Cortex

1. Kiyoshige T, Takashi S, Mitsuhiko M: The comparison of effects of various anesthetics on expression of Fos protein in the rat brain. Neuroscience Letter 1994, 176(1): 59-62.10.1016/0304-3940(94)90871-0Search in Google Scholar

2. Mitcheltree DH, Serfass WM, Tzilkowski RL, Peper MT, Whary RP: Physiological responses of fishers to immobilization with ketamine, ketamine-xylazine, or Telazol. Wildlife Society Bulletin 1999, 27(3): 582-591.Search in Google Scholar

3. Golden HN, Shults BS, Kunkel KE: Immobilization of wolverines with Telazol from a helicopter. Wildlife Society Bulletin 2002, 30(2): 492-497.Search in Google Scholar

4. Janovsky M, Tataruch F, Ambuehl M, Giacometti M: A Zoletil®-Rompun® mixture as an alternative to the use of opioids for immobilization of feral red deer. Journal of Wildlife Diseases 2000, 36(4): 663-669.10.7589/0090-3558-36.4.66311085427Search in Google Scholar

5. Hellyer P, Muir WW, Hubbell JA, Sally J: Cardio respiratory effects of the intravenous administration of tiletamine-zolazepam to cats. Veterinary Surgery 1988, 17(7): 105-110.10.1111/j.1532-950X.1988.tb00287.x3238874Search in Google Scholar

6. Jang HS, Kwon YS, Lee MG, Jang KH: The effect of tiletamine/zolazepam combination with xylazine or medetomidine on electroencephalograms in dogs. Journal of Veterinary Medical Science 2004, 66(5): 501-507.10.1292/jvms.66.50115187359Search in Google Scholar

7. Natalini CC, Alves SD, Guedes AG, Polydoro AS, Brondani JT, Bopp S: Epidural administration of tiletamine/zolazepam in horses. Veterinary Anaesthesia and Analgesia 2004, 31(4): 79-85.10.1111/j.1467-2987.2004.00155.x15053744Search in Google Scholar

8. Lu DZ, Fan HG, Ma K, Jiang S, Wang HB: Effect of Addition of Tramadol to Tiletamine/ zolazepam-Xylazine Anaesthesia in Miniature Pigs. Veterinary Record 2010, 167(13): 489-492.10.1136/vr.c445820871083Search in Google Scholar

9. Miller BF, Muller LI, Doherty T, Osborn DA, Miller KV, Warren RJ: Effectiveness of antagonists for tiletamine-zolazepam/xylazine immobilization in female white-tailed deer. Journal of Wildlife Diseases 2004, 40(3): 533-537.10.7589/0090-3558-40.3.53315465721Search in Google Scholar

10. Merwin DS, Milspaugh JJ, Brundige GC, Schultz D, Tyner CL: Immobilization of freeranging Rocky Mountain bighorn sheep, Ovis canadensis canadensis, ewes with Telazol® and xylazine hydrochloride. Canadian Field-Naturalist 2000, 114(3): 471 -475.Search in Google Scholar

11. Cattet MR, Caulkett NA, Stenhouse GB: The comparative effects of chemical immobilizing drug and method of capture on the health of grizzly bears. Thirteenth International Conference on Bear Research and Management, Jackson, Wyoming 2001, 5: 20-26.Search in Google Scholar

12. Belant JL: Belant Field Immobilization of Raccoons (Procyon lotor) with Telazol and Xylazine. Journal of Wildlife Disease 2004, 40(4): 787-790.10.7589/0090-3558-40.4.78715650101Search in Google Scholar

13. Belant JL: Tiletamine-zolazepam-xylazine immobilization of American marten (Martes Americana). Journal of Wildlife Disease 2005, 41(3): 659-663.10.7589/0090-3558-41.3.65916244082Search in Google Scholar

14. Belant JL: Tiletamine-zolazepam-xylazine Immobilization of Fishers (Martes pennanti). Journal of Wildlife Disease 2007, 43(2): 279-285.10.7589/0090-3558-43.2.27917495314Search in Google Scholar

15. Jalanka HH, Roeken BO: The use of medetomidine-ketamine combinations, and atipamezole in nondomestic mammals: a review. Journal of Zoo & Wildlife Medicine 1990, 21(3): 259-282.Search in Google Scholar

16. Dematteis A, Menzano A, Canavese G, Meneguz PG, Rossi L: Anaesthesia of freeranging Northern chamois (Rupicapra rupicapra) with xylazine/ketamine and reversal with atipamezole. European Journal of Wildlife Research 2009, 55(6): 567 -573.10.1007/s10344-009-0270-7Search in Google Scholar

17. Jung SY, Kim MS, Lee NY, Kim SY, Seo KM, Nam TC: The reverse effects of atipamezole on medetomidine-tiletamine/zolazepam combination anesthesia in the green iguana (Iguana iguana). Journal of Veterinary clinics 2006, 23(1): 18-21.Search in Google Scholar

18. Heaton-Jones TG, Ko JC, Heaton-Jones DL: Evaluation of medetomidine-ketamine anesthesia with atipamezole reversal in American alligators (Alligator Mississippi -ensis). Journal of Zoo & Wildlife Medicine 2002, 33(1): 36-44.10.1638/1042-7260(2002)033[0036:EOMKAW]2.0.CO;2Search in Google Scholar

19. Ezgi T, Lutfiye K, Ayfer Y: Effect of γ-glutamylcysteine ethylester on the levels of c-fos mRNA expression, glutathione and reactive oxygen species formation in kainic acid excitotoxicity. Journal of Pharmacy and Pharmacology 2010, 62(8): 1010-1017.10.1111/j.2042-7158.2010.01122.xSearch in Google Scholar

20. Sharp FR, Sagar SM: Alterationa in gene expression as an index of neuronal injury: heat shock and the immediate early gene response. Neurotoxicology 1994, 15(1): 51-59.Search in Google Scholar

21. Dragunow M, Faull R: The use of c-fos as metabolic marker in neuronal pathway tracing. Journal of Neuroscience Methods 1989, 29(3): 261-265.10.1016/0165-0270(89)90150-7Search in Google Scholar

22. Griffiths R, Malcolm C, Ritchie L, Frandsen A, Schousboe A, Scott M, Rumsby P, Meredith C: Association of c-fos mRNA expression and excitotoxicity in primary cultures of mouse neocortical and cerebellar neurons. Journal of Neuroscience Research 1997, 48(6): 533-542.10.1002/(SICI)1097-4547(19970615)48:6<533::AID-JNR6>3.0.CO;2-BSearch in Google Scholar

23. Willoughby JO, Mackenzie L, Medvedev A, Hiscock JJ: Fos induction following systemic kainic acid: early expression in hippocampus and later widespread expression correlated with seizure. Neurosience 1997, 77(2): 379-392.10.1016/S0306-4522(96)00462-9Search in Google Scholar

24. Niles LP, Smith LJ, Tenn CC: Modulation of c-fos expression in the rat striatum by diazepam. Neuroscience Letters 1997, 236(1): 5-8.10.1016/S0304-3940(97)00755-6Search in Google Scholar

25. Kumar A, Mann HJ, Remmel RP: Determination of constituents of Telazol® -tiletamine and zolazepam by a gas chromatography/mass spectrometry-based method. Journal of Chromatography B 2006, 842(2): 131-135.10.1016/j.jchromb.2006.05.014Search in Google Scholar

26. Lee CC, Lin YY, Hsu CW, Chu SJ, Tsai SH: Movement disorder caused by abuse of veterinary anesthesia containing tiletamine. American Journal of Emergency Medicine 2009, 27(8): 1022.e5-1022.e6.10.1016/j.ajem.2008.12.030Search in Google Scholar

27. Nieradko B, Borzecki A: Effect of bifenthrin on memory processes, movement activity, and coordination in mice exposed to transient cerebral oligaemia. Bulletin of Veterinary Institute in Pulawy 2008, 52(2): 291-294.Search in Google Scholar

28. Yin BS, Wang HB, Gong DQ, Li GJ, Gao L: Effects of Xylazine on glutamate and GABA contents in the hippocampus and thalamencephal in the rat. Bulletin of Veterinary Institute in Pulawy 2011, 55(3): 537-539.Search in Google Scholar

29. Lipták T, Capík I, Ledecký V, Nagy O, Kuricová M, Tóthová C, Mad Aďari A, Farbáková J, Petrovič V, Horňák S: Cardiorespiratory and hemodynamic effects of medetomidine or xylazine with atropine and diazepam premedication for total intravenous anesthesia induced and maintained with propofol/fentanyl in dogs undergoing surgery. Acta Veterinaria- Beograd 2014, 64 (4): 466-476. 10.2478/acve-2014-0044Search in Google Scholar

30. Krukoff TL, Morton TL, Harris KH, Jhamandas JH: Expression of c-fos protein in rat brain elicited by electrical stimulation of the pontine parabrachial nucleus. Journal of Neuroscience 1992, 12(9): 3582-3590.10.1523/JNEUROSCI.12-09-03582.1992Search in Google Scholar

31. Shimode N, Fukuoka T, Tanimoto M, Tashiro C, Tokunaga A, Noguchi K: The effects of dexmedetomidine and halothane on Fos expression in the spinal dorsal horn using a rat postoperative pain model. Neuroscience Letter 2003, 343(1): 45-48.10.1016/S0304-3940(03)00309-4Search in Google Scholar

32. Miller J: induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. Neurochemistry 1990, 54(4): 1453-1455.10.1111/j.1471-4159.1990.tb01983.xSearch in Google Scholar

33. Pertovaara A, Haapalinna A, Sirviö J, Virtanen R: Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective α2-Adrenoceptor Antagonist. CNS Drug Reviews 2005, 11(3): 273-288.10.1111/j.1527-3458.2005.tb00047.xSearch in Google Scholar

34. Ruth LS, Michele CG, Patrice GG: Atipamezole-precipitated clonidine withdrawal induces c-Fos expression in rat central nervous system. Brain Research 1997, 764(1-2): 81-92. 10.1016/S0006-8993(97)00424-1Search in Google Scholar